With scientific excellence and an ambitious vision, the Cedars-Sinai Samuel Oschin Comprehensive Cancer Institute is giving hope to patients with mesothelioma. With Tower’s support, Cedars-Sinai team members will collaborate across disciplines to investigate how mesothelioma begins, how it grows, and how to halt its progression. Team members will conduct research that spans the continuum – from novel laboratory explorations, to translational experiments, to clinical trials that test the safety and efficacy of new interventions for the prevention and treatment in humans. Clinical scientists and basic scientists will submit proposals and, after a rigorous peer-review process by the multi-disciplinary committee, a winning project(s) will be selected.